Developer docs
API playgroundTry for free, no card

Search company profiles

QC Kinetix

Full company profile

uuid0006tk6

Namestring
QC Kinetix
Legal namestring
QC Kinetix
Websiteurl
qckinetix.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

QC Kinetix is a Charlotte, North Carolina-based regenerative medicine franchise founded in 2017, operating as the largest regenerative medicine franchise in North America with more than 100 clinic locations across 30+ states. The company provides non-surgical, drug-free treatments for chronic joint pain, osteoarthritis, sports injuries, and musculoskeletal conditions, using orthobiologic protocols built on the patient's own biologics — Platelet-Rich Plasma (PRP) with a stated 10-billion platelet dosing standard, Bone Marrow Aspirate Concentrate (BMAC), Plasma Protein Concentrate (PPC/A2M), and Class IV laser therapy — typically deployed as a sequenced, multi-layered protocol under ultrasound guidance.

The company operates a two-sided business model. On the franchise side, QC Kinetix licenses its brand, standardized clinical protocols, training, and national marketing to franchisee operators who run individual clinics under the QC Kinetix name, generating franchise fees and royalties. On the patient side, treatments are sold directly to consumers through free consultations and paid out-of-pocket, as regenerative medicine is generally not covered by insurance. Patient acquisition is driven by a multi-channel marketing approach spanning SEO/content marketing, social media, earned media, community programs (including the 'Pain Free for Heroes' military discount initiative), webinars, and the company's annual Charlotte medical conference. Ancillary sub-brands — QC Joint Health supplements and QC Pain Cream — extend the brand into consumer health products.

Leadership includes CEO Peter Holt (appointed April 2026, previously president and CEO of The Joint Corp. where he scaled the network from ~300 to nearly 1,000 clinics), National Medical Director Dr. Mitchell Sheinkop (board-certified orthopedic surgeon), and regional operators such as Richard Paz (President and CEO of QC Kinetix South Florida, overseeing 12 clinics). The company serves three core customer segments — adults with chronic joint pain (primary), athletes and active individuals, and U.S. veterans/active-duty military — and reports 46,000+ cumulative patient lives transformed.

Short descriptiontext

QC Kinetix is a Charlotte-based regenerative medicine franchise operating 100+ clinics across 30+ states, offering non-surgical orthobiologic treatments (PRP, BMAC, A2M/PPC, laser therapy) to patients with chronic joint pain, sports injuries, and musculoskeletal conditions on a cash-pay basis.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCharlotte, United States
HQ citystring
Charlotte
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regenerative medicine, orthobiologic treatments, PRP therapy, non-surgical pain relief, joint pain treatment
Industry2 codes
PRIMARYHLAKALAM
Pain Management (Spine & Musculoskeletal)
SECONDARYHLAAABAJ
Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
NAICS code1 code
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
SIC code2 codes
  • Services-Health Services8000
  • Services-Misc Health & Allied Services, Nec8090
Product category
Regenerative Medicine Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Regenerative Medicine Treatment Services
TypeOne Time License
Description

QC Kinetix generates revenue through providing regenerative medicine treatments including PRP therapy, cellular therapy, BMAC, plasma protein concentrate, and Class IV laser therapy. Treatments are sold as one-time procedures or treatment protocols, typically paid out-of-pocket by patients as these services are generally not covered by insurance.

qckinetix.com
2Franchise Fees
TypeLicensing Royalties
Description

The company operates as a franchise system and generates revenue through franchise fees from individual clinic operators who pay for the right to use the QC Kinetix brand, protocols, and operational support.

qckinetix.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Free consultation followed by personalized treatment plan
ModelOtherBilling cadencePay-as-you-go
Notes

Free initial consultation to determine candidacy for treatment. Pricing is quote-based and discussed during consultation. Patients pay out-of-pocket as insurance typically does not cover regenerative medicine treatments.

qckinetix.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1QC Joint Health
Description

Joint and bone health supplement brand operated by QC Kinetix

qckinetix.com
+1 more record
Core offering1 text field

QC Kinetix provides non-surgical regenerative medicine treatments for chronic joint pain, arthritis, sports injuries, and musculoskeletal conditions. Services are delivered through a network of 100+ franchised clinics across 30+ U.S. states and include PRP (Platelet-Rich Plasma) therapy, cellular therapy (BMAC), plasma protein concentrate (PPC/A2M), and Class IV laser therapy administered using the patient's own biologics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 46,000+ patient lives transformed
+4 more records
Product overview1 text field

QC Kinetix operates as a regenerative medicine franchise offering a comprehensive suite of non-surgical, drug-free treatments for musculoskeletal pain and joint conditions. The core offering centers on orthobiologics treatments that utilize the patient's own biological materials to stimulate natural healing. The product portfolio includes: Cellular Therapy (using bone marrow-derived biologics), PRP Treatments (platelet-rich plasma), Class IV Laser Therapy, Plasma Protein Concentrate (PPC), and BMAC Treatment as primary treatment modalities. These are organized under treatment specialties including Regenerative Orthopedics and Regenerative Sports Medicine. The treatments work synergistically as part of a personalized multi-layered protocol: typically starting with plasma therapy, followed by A2M treatment, then BMAC, and finally PRP. The company operates over 100 clinic locations across 30+ states serving patients with chronic joint pain, sports injuries, and degenerative conditions as an alternative to surgery.

Product and service1 record
1PRP Treatments (Platelet-Rich Plasma)
CategoryRegenerative medicine treatment
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Cleveland Clinic's Center for Regenerative Medicine offers PRP and cellular therapies as part of a much broader hospital-system portfolio. Comparable treatment menu but with academic-medical-center credibility, insurance billing, and research backing that QC Kinetix lacks.

TypeDirect peer
Description

NovaGenix is a regenerative medicine clinic group providing PRP, stem cell and hormone replacement therapies for joint pain and orthopedic conditions. Comparable cash-pay model, treatment menu, and consumer patient base.

TypeDirect peer
Description

Atlas Health operates a multi-location regenerative medicine clinic network offering PRP, stem-cell and hormone therapies for chronic pain and orthopedic conditions. Direct comparable in cash-pay orthobiologics and patient demographic.

TypeBroad incumbent
Description

Mayo Clinic's Regenerative Medicine program offers PRP and biologic therapies within a major hospital system. Comparable orthobiologics treatments but operating under an academic medical center with established research and reimbursement infrastructure.

TypeEmerging player
Description

Celling Biosciences provides autologous point-of-care cell-therapy systems used by orthopedic and pain-medicine physicians. Comparable in orthobiologics focus, though positioned as a technology supplier to clinics rather than a consumer-facing franchise operator.

TypeDirect peer
Description

Global Stem Cells Group is an international regenerative medicine company operating clinics and training providers in stem-cell and PRP therapies. Comparable in treatment portfolio and cash-pay clinic operations targeting joint pain and orthopedic conditions.

TypeOthers
Description

The Joint Corp. is the largest chiropractic franchise in the U.S. (the prior company of QC Kinetix's new CEO Peter Holt). Comparable as a franchise-system business model with similar unit-economics profile, marketing flywheel, and scaling playbook, although the underlying clinical service differs.

8BioGenix
TypeDirect peer
Description

BioGenix operates a network of regenerative-medicine clinics offering PRP and cellular therapies for joint pain. Direct comparable in treatment modality, patient demographic, and cash-pay clinic model.

TypeDirect peer
Description

Flexogenix runs a multi-location clinic network providing non-surgical regenerative treatments for joint pain using PRP and other orthobiologics. Comparable in offering menu, patient demographic, and direct-to-consumer cash-pay model.

TypeDirect peer
Description

Regenexx operates the largest direct competitor network in regenerative orthopedics, offering PRP and stem-cell-based treatments for musculoskeletal conditions through a clinic affiliate model. Most directly comparable in patient targeting, treatment menu, and cash-pay economics to QC Kinetix.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

QC Kinetix

Regenerative Medicine Servicesqckinetix.com

QC Kinetix is a Charlotte-based regenerative medicine franchise operating 100+ clinics across 30+ states, offering non-surgical orthobiologic treatments (PRP, BMAC, A2M/PPC, laser therapy) to patients with chronic joint pain, sports injuries, and musculoskeletal conditions on a cash-pay basis.

What QC Kinetix does

QC Kinetix is a Charlotte, North Carolina-based regenerative medicine franchise founded in 2017, operating as the largest regenerative medicine franchise in North America with more than 100 clinic locations across 30+ states. The company provides non-surgical, drug-free treatments for chronic joint pain, osteoarthritis, sports injuries, and musculoskeletal conditions, using orthobiologic protocols built on the patient's own biologics — Platelet-Rich Plasma (PRP) with a stated 10-billion platelet dosing standard, Bone Marrow Aspirate Concentrate (BMAC), Plasma Protein Concentrate (PPC/A2M), and Class IV laser therapy — typically deployed as a sequenced, multi-layered protocol under ultrasound guidance.

The company operates a two-sided business model. On the franchise side, QC Kinetix licenses its brand, standardized clinical protocols, training, and national marketing to franchisee operators who run individual clinics under the QC Kinetix name, generating franchise fees and royalties. On the patient side, treatments are sold directly to consumers through free consultations and paid out-of-pocket, as regenerative medicine is generally not covered by insurance. Patient acquisition is driven by a multi-channel marketing approach spanning SEO/content marketing, social media, earned media, community programs (including the 'Pain Free for Heroes' military discount initiative), webinars, and the company's annual Charlotte medical conference. Ancillary sub-brands — QC Joint Health supplements and QC Pain Cream — extend the brand into consumer health products.

Leadership includes CEO Peter Holt (appointed April 2026, previously president and CEO of The Joint Corp. where he scaled the network from ~300 to nearly 1,000 clinics), National Medical Director Dr. Mitchell Sheinkop (board-certified orthopedic surgeon), and regional operators such as Richard Paz (President and CEO of QC Kinetix South Florida, overseeing 12 clinics). The company serves three core customer segments — adults with chronic joint pain (primary), athletes and active individuals, and U.S. veterans/active-duty military — and reports 46,000+ cumulative patient lives transformed.

QC Kinetix firmographics

Firmographics
Name
QC Kinetix
Legal name
QC Kinetix
Website
https://qckinetix.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
QC Kinetix is a Charlotte-based regenerative medicine franchise operating 100+ clinics across 30+ states, offering non-surgical orthobiologic treatments (PRP, BMAC, A2M/PPC, laser therapy) to patients with chronic joint pain, sports injuries, and musculoskeletal conditions on a cash-pay basis.
Ownership category
akta.pro rank

QC Kinetix industry classification

Industry
Product category
Regenerative Medicine Services
NAICS
Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
SIC
Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLAKALAM
Pain Management (Spine & Musculoskeletal)
SECONDARYHLAAABAJ
Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)

Keywords

  • Regenerative medicine
  • Orthobiologic treatments
  • PRP therapy
  • Non-surgical pain relief
  • Joint pain treatment

Where QC Kinetix is headquartered

Location

Headquarters

HQ city
Charlotte
HQ country
United States
HQ region
North America

Offices1 record

Markets served

QC Kinetix business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Regenerative Medicine Treatment Services: QC Kinetix generates revenue through providing regenerative medicine treatments including PRP therapy, cellular therapy, BMAC, plasma protein concentrate, and Class IV laser therapy. Treatments are sold as one-time procedures or treatment protocols, typically paid out-of-pocket by patients as these services are generally not covered by insurance.
  2. Franchise Fees: The company operates as a franchise system and generates revenue through franchise fees from individual clinic operators who pay for the right to use the QC Kinetix brand, protocols, and operational support.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goFree consultation followed by personalized treatment plan

Go-to-market motion2 records

Distribution channels2 records

Marketing channels10 records

QC Kinetix product offering

Product offering

Core offering

QC Kinetix provides non-surgical regenerative medicine treatments for chronic joint pain, arthritis, sports injuries, and musculoskeletal conditions. Services are delivered through a network of 100+ franchised clinics across 30+ U.S. states and include PRP (Platelet-Rich Plasma) therapy, cellular therapy (BMAC), plasma protein concentrate (PPC/A2M), and Class IV laser therapy administered using the patient's own biologics.

Product overview

QC Kinetix operates as a regenerative medicine franchise offering a comprehensive suite of non-surgical, drug-free treatments for musculoskeletal pain and joint conditions. The core offering centers on orthobiologics treatments that utilize the patient's own biological materials to stimulate natural healing. The product portfolio includes: Cellular Therapy (using bone marrow-derived biologics), PRP Treatments (platelet-rich plasma), Class IV Laser Therapy, Plasma Protein Concentrate (PPC), and BMAC Treatment as primary treatment modalities. These are organized under treatment specialties including Regenerative Orthopedics and Regenerative Sports Medicine. The treatments work synergistically as part of a personalized multi-layered protocol: typically starting with plasma therapy, followed by A2M treatment, then BMAC, and finally PRP. The company operates over 100 clinic locations across 30+ states serving patients with chronic joint pain, sports injuries, and degenerative conditions as an alternative to surgery.

Differentiator

Problem solved

Functional benefit

Brands

  • QC Joint Health: Joint and bone health supplement brand operated by QC Kinetix
  • QC Pain Cream

Products and services

  • PRP Treatments (Platelet-Rich Plasma)

Quantifiable outcome

  • 46,000+ patient lives transformed
  • +4 more outcomes

Companies that use QC Kinetix

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

QC Kinetix technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

QC Kinetix partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves7 records

Expansion highlights3 records

QC Kinetix competitors and assessment

Company assessment

Broad incumbents

  • Cleveland Clinic Regenerative Medicine: Cleveland Clinic's Center for Regenerative Medicine offers PRP and cellular therapies as part of a much broader hospital-system portfolio. Comparable treatment menu but with academic-medical-center credibility, insurance billing, and research backing that QC Kinetix lacks.
  • Mayo Clinic Regenerative Medicine: Mayo Clinic's Regenerative Medicine program offers PRP and biologic therapies within a major hospital system. Comparable orthobiologics treatments but operating under an academic medical center with established research and reimbursement infrastructure.

Direct peers

  • NovaGenix: NovaGenix is a regenerative medicine clinic group providing PRP, stem cell and hormone replacement therapies for joint pain and orthopedic conditions. Comparable cash-pay model, treatment menu, and consumer patient base.
  • Atlas Health Medical Group: Atlas Health operates a multi-location regenerative medicine clinic network offering PRP, stem-cell and hormone therapies for chronic pain and orthopedic conditions. Direct comparable in cash-pay orthobiologics and patient demographic.
  • Global Stem Cells Group: Global Stem Cells Group is an international regenerative medicine company operating clinics and training providers in stem-cell and PRP therapies. Comparable in treatment portfolio and cash-pay clinic operations targeting joint pain and orthopedic conditions.
  • BioGenix: BioGenix operates a network of regenerative-medicine clinics offering PRP and cellular therapies for joint pain. Direct comparable in treatment modality, patient demographic, and cash-pay clinic model.
  • Flexogenix: Flexogenix runs a multi-location clinic network providing non-surgical regenerative treatments for joint pain using PRP and other orthobiologics. Comparable in offering menu, patient demographic, and direct-to-consumer cash-pay model.
  • Regenexx: Regenexx operates the largest direct competitor network in regenerative orthopedics, offering PRP and stem-cell-based treatments for musculoskeletal conditions through a clinic affiliate model. Most directly comparable in patient targeting, treatment menu, and cash-pay economics to QC Kinetix.

Emerging players

  • Celling Biosciences: Celling Biosciences provides autologous point-of-care cell-therapy systems used by orthopedic and pain-medicine physicians. Comparable in orthobiologics focus, though positioned as a technology supplier to clinics rather than a consumer-facing franchise operator.

Others

  • The Joint Corp. The Joint Corp. is the largest chiropractic franchise in the U.S. (the prior company of QC Kinetix's new CEO Peter Holt). Comparable as a franchise-system business model with similar unit-economics profile, marketing flywheel, and scaling playbook, although the underlying clinical service differs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

QC Kinetix social profiles

Digital presence

QC Kinetix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

QC Kinetix leadership team

Management profile

Number of profiles

Profiles4 records

QC Kinetix funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

QC Kinetix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about QC Kinetix

What does QC Kinetix do?

QC Kinetix provides non-surgical regenerative medicine treatments for chronic joint pain, arthritis, sports injuries, and musculoskeletal conditions. Services are delivered through a network of 100+ franchised clinics across 30+ U.S. states and include PRP (Platelet-Rich Plasma) therapy, cellular therapy (BMAC), plasma protein concentrate (PPC/A2M), and Class IV laser therapy administered using the patient's own biologics.

Is QC Kinetix a public or private company?

QC Kinetix is a private company. It is classified as unknown and is currently operating.

When was QC Kinetix founded?

QC Kinetix was founded in 2017. It employs 51 to 100 people.

Where is QC Kinetix based?

QC Kinetix is headquartered in Charlotte, United States, in the North America region.

How does QC Kinetix make money?

Two revenue lines are on record. Regenerative Medicine Treatment Services are the primary driver. The others are franchise Fees.

Who are QC Kinetix's main competitors?

Broad incumbents on record are Cleveland Clinic Regenerative Medicine and Mayo Clinic Regenerative Medicine. Direct peers are NovaGenix, Atlas Health Medical Group, Global Stem Cells Group, BioGenix, Flexogenix and Regenexx. Celling Biosciences is listed as an emerging player. The Joint Corp. is listed as an others.

Does QC Kinetix have an API?

No public API is recorded for QC Kinetix.

What industry is QC Kinetix in?

QC Kinetix's product category is Regenerative Medicine Services. Its primary akta.pro industry code is HLAKALAM, Pain Management (Spine & Musculoskeletal), with a secondary code of HLAAABAJ, Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring). Its NAICS code is 62134 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireQC Kinetix Expands Colorado Presence with Leading Regenerative Medicine Specialists Serving Denver and Colorado SpringsQC Kinetix expanded its Colorado presence with clinics in Aurora, Highlands Ranch, Superior, and Colorado Springs, led by Nicole Huntress, MD. The team offers regenerative orthopedic therapies for joint pain, arthritis, and sports injuries, aiming to provide non-surgical alternatives to traditional pain management.Business Wire BlogQC Kinetix Taps Former The Joint Corp. CEO Peter Holt to Lead Next Phase of National GrowthQC Kinetix announced the appointment of Peter Holt as its new chief executive officer to lead the company's next phase of national growth. Holt previously served as president and CEO of The Joint Corp. for more than eight years, during which he expanded that franchise system from approximately 300 clinics to nearly 1,000 nationwide, creating the country's largest chiropractic clinic network. Founded in 2017 and headquartered in Charlotte, North Carolina, QC Kinetix operates the largest regenerative medicine franchise in North America with more than 100 clinics across the U.S.EIN PresswireQC Kinetix Opens New Regenerative Medicine Clinic in Stuart, FloridaQC Kinetix has opened a new regenerative medicine clinic in Stuart, Florida, expanding its South Florida footprint to 12 clinics and bringing advanced biologic therapies to residents of Stuart, Port St. Lucie, and the surrounding Treasure Coast communities. The clinic offers non-surgical treatments for musculoskeletal and joint pain, including stem cell therapy and PRP therapy, as an alternative to traditional orthopedic treatments. Richard Paz, President and CEO of QC Kinetix South Florida, stated the mission is to make regenerative medicine accessible to patients seeking alternatives to surgery or long-term pain medication reliance.EIN PresswireQC Kinetix Reopens in Fort Myers with Advanced Regenerative Medicine TreatmentsQC Kinetix announced the reopening of its Fort Myers clinic in Southwest Florida on February 19, 2026, with expanded services offering regenerative medicine treatments including platelet-rich plasma (PRP) therapy and stem cell treatments as non-surgical alternatives to traditional interventions. The clinic, led by Dr. Sander Fernandez and seven additional providers, implements a 10-billion platelet dosing standard for PRP therapy and serves patients suffering from chronic pain, sports injuries, and joint conditions. QC Kinetix, founded in 2017 and headquartered in Charlotte, North Carolina, operates as the largest regenerative medicine franchise in North America with over 100 clinics across the United States.PR NewswirePain Free for Heroes: QC Kinetix Honors United States Military with Month-Long Giveback InitiativeQC Kinetix, the largest regenerative medicine franchise in North America, launched a Veterans Day Initiative throughout November offering $500 off first treatments for veterans and active-duty service members at participating clinics across the United States. The initiative aims to make regenerative medicine more accessible for military personnel dealing with joint pain, chronic pain, and service-related injuries. The company, founded in 2017 and based in Charlotte, North Carolina, operates over 100 clinics nationwide with plans to expand to 350 locations.MorningstarQC Kinetix Hosts Inaugural Medical Conference, Showcasing Clinical Depth and Innovation in Regenerative OrthobiologicsQC Kinetix hosted its first annual medical conference in Charlotte, North Carolina, on October 30, 2025, bringing together physicians for education on regenerative orthobiologics. The event included sessions on PRP, shockwave therapy, and a live bone marrow aspiration demonstration. The company plans to expand from over 100 clinics to 350 nationwide.PR NewswireQC Kinetix Hosts Inaugural Medical Conference, Showcasing Clinical Depth and Innovation in Regenerative OrthobiologicsQC Kinetix hosted its first annual medical conference in Charlotte, North Carolina, bringing together physicians and providers to focus on regenerative medicine and orthobiologics. The event emphasized clinical education, scientific innovation, and standardization across its expanding network, including live demonstrations and discussions on advanced treatments.PR NewswireQC Kinetix Relaunches Strategic Franchise Expansion Following Comprehensive Brand TransformationQC Kinetix, the largest regenerative medicine franchise in North America, has relaunched its national franchise development initiative following a year-long comprehensive brand transformation called QCK 2.0. Q2 2025 marked the company's first quarter of same-clinic sales growth in five quarters, with average clinic profitability increasing from 2.20% to 24.71%. The company plans to target 50 new franchise owners and 120 new clinics over the next 24 months, accelerating expansion six months ahead of schedule.PR NewswireQC Kinetix Becomes Presenting Sponsor of the National Pickleball League to Champion Active, Healthy LifestylesQC Kinetix, the largest regenerative medicine company in North America, has become the presenting sponsor of the National Pickleball League for its third season in 2025, branding the league as "NPL presented by QC Kinetix." The partnership aims to educate the league's Champions Pro (ages 50+) demographic on injury prevention and regenerative medicine alternatives to surgery. Founded in 2022, the NPL is the first professional pickleball league for players over 50 and comprises twelve teams across major U.S. metropolitan areas.